Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 474710-78-6 | MDL No. : | MFCD26967898 |
Formula : | C10H7BrN2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | AEWGSIACZRIQON-UHFFFAOYSA-N |
M.W : | 267.08 | Pubchem ID : | 22031300 |
Synonyms : |
|
Num. heavy atoms : | 15 |
Num. arom. heavy atoms : | 10 |
Fraction Csp3 : | 0.1 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 58.52 |
TPSA : | 52.08 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.21 cm/s |
Log Po/w (iLOGP) : | 2.46 |
Log Po/w (XLOGP3) : | 2.42 |
Log Po/w (WLOGP) : | 2.18 |
Log Po/w (MLOGP) : | 1.6 |
Log Po/w (SILICOS-IT) : | 2.44 |
Consensus Log Po/w : | 2.22 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.38 |
Solubility : | 0.111 mg/ml ; 0.000415 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.16 |
Solubility : | 0.186 mg/ml ; 0.000698 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.26 |
Solubility : | 0.0147 mg/ml ; 0.0000552 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 1.76 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 769916-07-6 ]
6-Bromoquinazoline-4-carboxylic acid
Similarity: 0.93
[ 882679-56-3 ]
Ethyl 6-bromoisoquinoline-3-carboxylate
Similarity: 0.80
[ 660830-62-6 ]
Ethyl 7-bromoisoquinoline-3-carboxylate
Similarity: 0.80
[ 1416713-22-8 ]
6-Bromoisoquinoline-3-carboxylic acid
Similarity: 0.75
[ 1204334-27-9 ]
6-Bromoquinazoline-4-carbonitrile
Similarity: 0.70
[ 882679-56-3 ]
Ethyl 6-bromoisoquinoline-3-carboxylate
Similarity: 0.80
[ 660830-62-6 ]
Ethyl 7-bromoisoquinoline-3-carboxylate
Similarity: 0.80
[ 1036755-95-9 ]
Methyl 2-oxo-1,2-dihydroquinazoline-6-carboxylate
Similarity: 0.70
[ 845827-15-8 ]
Methyl [2,3'-bipyridine]-6'-carboxylate
Similarity: 0.68
[ 27104-73-0 ]
Methyl isoquinoline-3-carboxylate
Similarity: 0.68
[ 769916-07-6 ]
6-Bromoquinazoline-4-carboxylic acid
Similarity: 0.93
[ 1036755-95-9 ]
Methyl 2-oxo-1,2-dihydroquinazoline-6-carboxylate
Similarity: 0.70
[ 1204334-27-9 ]
6-Bromoquinazoline-4-carbonitrile
Similarity: 0.70